Pharmaxis Announces A$4.4m Placement

14th Apr 21

Release Date: 14/04/2021 9:25am


  • A$4.4m being raised in a placement to institutional investors
  • A$20m pro-forma cash balance post raising  
  • Strengthened balance sheet to support ongoing clinical studies in myelofibrosis and skin scarring  
  • Issue price of A$0.08 represents a 1.3% premium to last closing price as at 12 April 2021
  • New shareholder Karst Peak Capital Limited invests A$3.2m for a 8.9% holding in the Company
  • Existing shareholder BVF Partners LP invests A$0.8m to maintain its holding at 19.5%

Read full media release - pdf

Categories: News and Media